Literature DB >> 22740094

A pathogenetic link between non-alcoholic fatty liver disease and celiac disease.

Ludovico Abenavoli1, Natasa Milic, Antonino De Lorenzo, Francesco Luzza.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) has recently been recognized as the leading cause of the abnormalities in the liver function tests in the Western countries. Celiac disease (CD) is a permanent immunological intolerance to gluten proteins in genetically predisposed individuals. CD has been reported in 4-13 % of the cases with steatohepatitis, although the pathogenesis of the liver steatosis in CD patients is unclear. Based on the literature data, it can be concluded that the inclusion of serological markers of CD should be a part of the general workup in the patients with steatosis when other causes of the liver disease are excluded and in the patients with NAFLD when metabolic risk factors are not evident.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22740094     DOI: 10.1007/s12020-012-9731-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  24 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Paul Angulo
Journal:  N Engl J Med       Date:  2002-04-18       Impact factor: 91.245

2.  Metformin versus dietary treatment in nonalcoholic hepatic steatosis: a randomized study.

Authors:  G A Garinis; B Fruci; A Mazza; M De Siena; S Abenavoli; E Gulletta; V Ventura; M Greco; L Abenavoli; A Belfiore
Journal:  Int J Obes (Lond)       Date:  2010-02-23       Impact factor: 5.095

Review 3.  The role of intestinal endotoxin in liver injury: a long and evolving history.

Authors:  James P Nolan
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

4.  Nutritional and metabolic considerations in the etiology of nonalcoholic steatohepatitis.

Authors:  V Nehra; P Angulo; A L Buchman; K D Lindor
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

5.  The prevalence of celiac disease among patients with non-alcoholic fatty liver disease in Iran.

Authors:  Ali Reza Rahimi; Nasser Ebrahimi Daryani; Hadi Ghofrani; Mohammad Taher; Mohammad Reza Pashaei; Sina Abdollahzade; Mohammad Kalani; Hosein Ajdarkosh
Journal:  Turk J Gastroenterol       Date:  2011-06       Impact factor: 1.852

Review 6.  Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.

Authors:  Thomas H Frazier; John K DiBaise; Craig J McClain
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-08-01       Impact factor: 4.016

7.  Celiac disease, primary biliary cirrhosis and helicobacter pylori infection: one link for three diseases.

Authors:  L Abenavoli; V Arena; F Giancotti; F M Vecchio; S Abenavoli
Journal:  Int J Immunopathol Pharmacol       Date:  2010 Oct-Dec       Impact factor: 3.219

8.  Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease.

Authors:  Luca Miele; Venanzio Valenza; Giuseppe La Torre; Massimo Montalto; Giovanni Cammarota; Riccardo Ricci; Roberta Mascianà; Alessandra Forgione; Maria L Gabrieli; Germano Perotti; Fabio M Vecchio; Gianlodovico Rapaccini; Giovanni Gasbarrini; Chris P Day; Antonio Grieco
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

9.  Searching for coeliac disease in patients with non-alcoholic fatty liver disease.

Authors:  M T Bardella; L Valenti; C Pagliari; M Peracchi; M Farè; A L Fracanzani; S Fargion
Journal:  Dig Liver Dis       Date:  2004-05       Impact factor: 4.088

10.  Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis.

Authors:  Ashkan Farhadi; Sushama Gundlapalli; Maliha Shaikh; Constantine Frantzides; Laura Harrell; Mary M Kwasny; Ali Keshavarzian
Journal:  Liver Int       Date:  2008-04-07       Impact factor: 5.828

View more
  14 in total

1.  Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease.

Authors:  Norelle R Reilly; Benjamin Lebwohl; Rolf Hultcrantz; Peter H R Green; Jonas F Ludvigsson
Journal:  J Hepatol       Date:  2015-01-21       Impact factor: 25.083

Review 2.  Non-alcoholic fatty liver disease: a diabetologist's perspective.

Authors:  Joseph M Pappachan; Farrah A Antonio; Mahamood Edavalath; Arjun Mukherjee
Journal:  Endocrine       Date:  2013-11-28       Impact factor: 3.633

3.  Hepatic steatosis and steatohepatitis: Are they really two distinct entities?

Authors:  Cory M Fielding; Paul Angulo
Journal:  Curr Hepatol Rep       Date:  2014-06-01

Review 4.  Potential role of Helicobacter pylori infection in nonalcoholic fatty liver disease.

Authors:  Meng Li; Zhe Shen; You-Ming Li
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

5.  The association between obstructive sleep apnea and non-alcoholic steatohepatitis: a retrospective nationwide inpatient sample analysis.

Authors:  Anas Renno; Yousef Abdel-Aziz; Yaseen Alastal; Sadik Khuder; Syed Hasan; Ragheb Assaly; Ali Nawras
Journal:  Clin Exp Hepatol       Date:  2021-03-25

Review 6.  Celiac Disease: Extraintestinal Manifestations and Associated Conditions.

Authors:  Amelie Therrien; Ciaran P Kelly; Jocelyn A Silvester
Journal:  J Clin Gastroenterol       Date:  2020-01       Impact factor: 3.174

Review 7.  4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine-recommendations for facing obesity, fatty liver and fibrosis epidemics.

Authors:  Francesca Maria Trovato; Daniela Catalano; Giuseppe Musumeci; Guglielmo M Trovato
Journal:  EPMA J       Date:  2014-12-07       Impact factor: 6.543

Review 8.  To screen or not to screen? Celiac antibodies in liver diseases.

Authors:  Janaína Luz Narciso-Schiavon; Leonardo Lucca Schiavon
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

9.  Clinicopathological and immunological characteristics and outcome of concomitant coeliac disease and non-alcoholic fatty liver disease in adults: a large prospective longitudinal study.

Authors:  Sanaa Kamal; Khaled K Aldossari; Dhalia Ghoraba; Sara Mahmoud Abdelhakam; Amgad H Kamal; Mohamad Bedewi; Leila Nabegh; Khaled Bahnasy; Tamer Hafez
Journal:  BMJ Open Gastroenterol       Date:  2018-01-29

10.  Increasing whole grain intake as part of prevention and treatment of nonalcoholic Fatty liver disease.

Authors:  Alastair B Ross; Jean-Philippe Godin; Kaori Minehira; John P Kirwan
Journal:  Int J Endocrinol       Date:  2013-05-16       Impact factor: 3.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.